Aspen Aerogels (NYSE:ASPN) Stock Price Up 3%

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price rose 3% during mid-day trading on Tuesday . The stock traded as high as $24.23 and last traded at $24.21. Approximately 68,557 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 1,164,649 shares. The stock had previously closed at $23.51.

Wall Street Analysts Forecast Growth

ASPN has been the topic of several recent research reports. Roth Mkm restated a “buy” rating and issued a $36.00 price target (up previously from $28.00) on shares of Aspen Aerogels in a research report on Wednesday, June 12th. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Piper Sandler raised their price objective on shares of Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 29th. HC Wainwright raised their price objective on shares of Aspen Aerogels from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Finally, Craig Hallum raised their price objective on shares of Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, June 14th. One analyst has rated the stock with a sell rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $30.75.

Aspen Aerogels Stock Up 0.0 %

The business’s 50 day simple moving average is $26.37 and its 200-day simple moving average is $19.06. The company has a market cap of $1.83 billion, a price-to-earnings ratio of -54.66 and a beta of 2.15. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.29 and a current ratio of 4.01.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.14. The company had revenue of $94.50 million during the quarter, compared to analyst estimates of $73.04 million. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. Sell-side analysts expect that Aspen Aerogels, Inc. will post 0.19 earnings per share for the current year.

Insider Activity at Aspen Aerogels

In related news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of Aspen Aerogels stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $23.50, for a total value of $82,250,000.00. Following the completion of the sale, the insider now owns 12,280,426 shares of the company’s stock, valued at approximately $288,590,011. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, major shareholder Wood River Capital, Llc sold 3,500,000 shares of Aspen Aerogels stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $23.50, for a total value of $82,250,000.00. Following the completion of the sale, the insider now owns 12,280,426 shares of the company’s stock, valued at approximately $288,590,011. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Corby C. Whitaker sold 55,159 shares of Aspen Aerogels stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the completion of the sale, the senior vice president now directly owns 131,533 shares of the company’s stock, valued at approximately $3,289,640.33. The disclosure for this sale can be found here. In the last 90 days, insiders sold 3,832,103 shares of company stock valued at $91,679,369. Insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Banque Cantonale Vaudoise raised its holdings in Aspen Aerogels by 37.5% in the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after acquiring an additional 1,252 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Aspen Aerogels by 15.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 14,580 shares of the construction company’s stock worth $257,000 after acquiring an additional 1,938 shares during the period. Thompson Davis & CO. Inc. raised its holdings in Aspen Aerogels by 14.7% in the 4th quarter. Thompson Davis & CO. Inc. now owns 24,150 shares of the construction company’s stock worth $381,000 after acquiring an additional 3,100 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Aspen Aerogels by 38.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after acquiring an additional 3,607 shares during the period. Finally, Bouvel Investment Partners LLC raised its holdings in Aspen Aerogels by 4.3% in the 4th quarter. Bouvel Investment Partners LLC now owns 94,318 shares of the construction company’s stock worth $1,488,000 after acquiring an additional 3,929 shares during the period. Institutional investors own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.